Combination therapy with sirolimus (rapamycin) and tacrolimus (FK-506) in treatment of refractory minimal change nephropathy, a clinical case report
Preeti Patel(Indo Soviet Friendship College of Pharmacy), Áine Burns(The Royal Free Hospital), P. Sweny(The Royal Free Hospital), Suvankar Pal(MRC Centre for Regenerative Medicine), Caroline Ashley(The Royal Free Hospital)
Cited by 14
Related Papers
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia
|Cell Reports|2019|333
Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs
|Life|2023|209
A comprehensive review on doxorubicin: mechanisms, toxicity, clinical trials, combination therapies and nanoformulations in breast cancer
|Drug Delivery and Translational Research|2024|141